Intra-Cellular Therapies, Inc. (ITCI) has 16 known insider and institutional holders on record. The largest holder is Mates Sharon with 190,000 shares. Other notable holders include Alafi Christopher D and RIGGS RORY B.
ITCI Insider Ownership
Top Holder
Mates Sharon
190,000 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Mates Sharon |
Chairman and CEO |
190,000 |
2025-03-31 |
|
| 2 |
Alafi Christopher D |
Director |
133,843 |
2021-05-28 |
|
| 3 |
Riggs Rory B |
Director |
131,512 |
2025-01-03 |
|
| 4 |
Lerner Richard A |
Director |
96,663 |
2021-10-04 |
|
| 5 |
Davis Robert E |
SVP, Chief Scientific Officer |
43,989 |
2019-01-08 |
|
| 6 |
Vanover Kimberly E. |
SVP, Early Stage Clinical Dev. |
27,068 |
2019-01-08 |
|
| 7 |
Satlin Andrew |
EVP and Chief Medical Officer |
26,754 |
2020-02-20 |
|
| 8 |
Narula Sanjeev |
Executive Vice President & CFO |
22,727 |
2025-02-04 |
|
| 9 |
Rawlins Michael |
Director |
16,757 |
2022-06-13 |
|
| 10 |
Neumann Mark |
EVP, Chief Commercial Officer |
13,133 |
2025-03-10 |
|
| 11 |
Halstead Michael |
President |
13,133 |
2025-03-10 |
|
| 12 |
Durgam Suresh K. |
EVP, Chief Medical Officer |
13,133 |
2025-03-10 |
|
| 13 |
Van Nostrand Robert L |
Director |
11,340 |
2024-07-02 |
|
| 14 |
Hineline Lawrence J. |
SVP of Finance, CFO |
4,539 |
2024-03-11 |
|
| 15 |
Salas Eduardo Rene |
Director |
2,951 |
2024-06-18 |
|
| 16 |
Marcus Joel S |
Director |
2,951 |
2024-06-18 |
|
No ownership data available for ITCI.
